REFERENCES
1. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
2. Sarasati A, Syahruddin MH, Nuryanti A, et al. Plant-derived exosome-like nanoparticles for biomedical applications and regenerative therapy. Biomedicines. 2023;11:1053.
3. Lo KJ, Wang MH, Ho CT, Pan MH. Plant-derived extracellular vesicles: a new revolutionization of modern healthy diets and biomedical applications. J Agric Food Chem. 2024;72:2853-78.
4. Kameli N, Dragojlovic-Kerkache A, Savelkoul P, Stassen FR. Plant-derived extracellular vesicles: current findings, challenges, and future applications. Membranes. 2021;11:411.
5. Huang D, Chen J, Zhao M, et al. Plant-derived extracellular vesicles: composition, function and clinical potential. J Transl Med. 2025;23:1065.
6. Zhuang X, Deng ZB, Mu J, et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J Extracell Vesicles. 2015;4:28713.
7. Di Raimo R, Mizzoni D, Aloi A, et al. Antioxidant effect of a plant-derived extracellular vesicles’ mix on human skin fibroblasts: induction of a reparative process. Antioxidants. 2024;13:1373.
8. Zhao WJ, Bian YP, Wang QH, et al. Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress. Acta Pharmacol Sin. 2022;43:645-58.
9. Ju S, Mu J, Dokland T, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther. 2013;21:1345-57.
10. Zeng YB, Deng X, Shen LS, et al. Advances in plant-derived extracellular vesicles: isolation, composition, and biological functions. Food Funct. 2024;15:11319-41.
11. Liu H, Dong T, Dong C, et al. Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases. J Nanobiotechnology. 2025;23:640.
12. Shi L, Guo C, Fang M, Yang Y, Yin F, Shen Y. Cross-kingdom regulation of plant microRNAs: potential application in crop improvement and human disease therapeutics. Front Plant Sci. 2024;15:1512047.
13. Yu Y, Tan N, Xu Z, et al. Cross-kingdom miRNA delivery by Panax notoginseng-derived extracellular-like nanoparticles vesicles restores neuronal function after ischemic injury. J Nanobiotechnology. 2026;24:242.
14. Li S, Zhang Y, Liu X, et al. Cross-kingdom delivery and putative gene modulation of androgen pathways by plant-derived exosome-like nanoparticles from polygoni multiflori radix promotes hair growth via miRNA cargo. Pharmacol Res. 2025;222:108033.
15. Jia M, He J, Bai W, et al. Cross-kingdom regulation by dietary plant miRNAs: an evidence-based review with recent updates. Food Funct. 2021;12:9549-62.
16. Yang L, Feng H. Cross-kingdom regulation by plant-derived miRNAs in mammalian systems. Animal Model Exp Med. 2023;6:518-25.
17. Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. 2012;22:107-26.
18. Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol. 2013;31:965-7.
19. Witwer KW, McAlexander MA, Queen SE, Adams RJ. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol. 2013;10:1080-6.
20. DeLucas M, Sánchez J, Palou A, Serra F. The impact of diet on miRNA regulation and its implications for health: a systematic review. Nutrients. 2024;16:770.
21. Tambaro F, Gallicchio C, Orlando S, Carnevale S, Muscaritoli M. The conundrum of XenomiRs and human health. Adv Nutr. 2025;16:100510.
22. Nunes A, Zhang T, Mu X, Robbins PD. Therapeutic application of extracellular vesicles in human diseases. Mol Ther. 2025;33:2243-51.
23. Zhang M, Viennois E, Prasad M, et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321-40.
24. Zhang S, Wang Q, Tan DEL, et al. Gut-liver axis: potential mechanisms of action of food-derived extracellular vesicles. J Extracell Vesicles. 2024;13:e12466.
25. Wu Q, Kan J, Fu C, et al. Insights into the unique roles of extracellular vesicles for gut health modulation: Mechanisms, challenges, and perspectives. Curr Res Microb Sci. 2024;7:100301.
26. Chang Z, Xu X, Xu Y, et al. Potential effects of functional foods and dietary supplements on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota. J Agric Food Chem. 2025;73:29247-80.
27. Fang X, Feng J, Zhu X, Feng D, Zheng L. Plant-derived vesicle-like nanoparticles: a new tool for inflammatory bowel disease and colitis-associated cancer treatment. Mol Ther. 2024;32:890-909.
28. Zhu MZ, Xu HM, Liang YJ, et al. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. J Nanobiotechnology. 2023;21:309.
29. Wang B, Zhuang X, Deng ZB, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014;22:522-34.
30. Cai Q, Halilovic L, Shi T, et al. Extracellular vesicles: cross-organismal RNA trafficking in plants, microbes, and mammalian cells. Extracell Vesicles Circ Nucl Acids. 2023;4:262-82.
31. Rome S. Biological properties of plant-derived extracellular vesicles. Food Funct. 2019;10:529-38.
32. Huang Y, Wang S, Cai Q, Jin H. Effective methods for isolation and purification of extracellular vesicles from plants. J Integr Plant Biol. 2021;63:2020-30.
33. Woith E, Guerriero G, Hausman JF, et al. Plant extracellular vesicles and nanovesicles: focus on secondary metabolites, proteins and lipids with perspectives on their potential and sources. Int J Mol Sci. 2021;22:3719.
34. Jeppesen DK, Zhang Q, Franklin JL, Coffey RJ. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 2023;33:667-81.
35. Cai Q, Qiao L, Wang M, et al. Plants send small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes. Science. 2018;360:1126-9.
36. He B, Cai Q, Qiao L, et al. RNA-binding proteins contribute to small RNA loading in plant extracellular vesicles. Nat Plants. 2021;7:342-52.
37. Baldrich P, Rutter BD, Karimi HZ, Podicheti R, Meyers BC, Innes RW. Plant extracellular vesicles contain diverse small RNA species and are enriched in 10- to 17-nucleotide “Tiny” RNAs. Plant Cell. 2019;31:315-24.
38. Pinedo M, de la Canal L, de Marcos Lousa C. A call for Rigor and standardization in plant extracellular vesicle research. J Extracell Vesicles. 2021;10:e12048.
39. Nueraihemaiti N, Dilimulati D, Baishan A, et al. Advances in plant-derived extracellular vesicle extraction methods and pharmacological effects. Biology. 2025;14:377.
40. Woith E, Melzig MF. Extracellular vesicles from fresh and dried plants-simultaneous purification and visualization using gel electrophoresis. Int J Mol Sci. 2019;20:357.
41. Han X, Zheng W, Sun Z, et al. Plant-derived exosomes: unveiling the similarities and disparities between conventional extract and innovative form. Phytomedicine. 2025;145:157087.
42. Liu J, Xiang J, Jin C, et al. Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression. J Nanobiotechnology. 2023;21:78.
43. Chin AR, Fong MY, Somlo G, et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res. 2016;26:217-28.
44. Mu J, Zhuang X, Wang Q, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr Food Res. 2014;58:1561-73.
45. Luo T, Hou L, Cao Y, et al. Tea extracellular vesicle-derived microRNAs contribute to alleviate intestinal inflammation by reprogramming macrophages. J Agric Food Chem. 2025;73:6745-57.
46. Wei C, Chen Y, Chen J, et al. miR166u -enriched Polygonatum sibiricum exosome-like nanoparticles alleviate colitis by improving intestinal barrier through the TLR4/AKT pathway. Int J Biol Macromol. 2025;318:144802.
47. Yang Y, Yang L, Deng H, et al. Coptis chinensis-derived extracellular vesicle-like nanoparticles delivered miRNA-5106 suppresses NETs by restoring zinc homeostasis to alleviate colitis. J Nanobiotechnology. 2025;23:444.
48. Díez-Sainz E, Aranaz P, Amri EZ, Riezu-Boj JI, Lorente-Cebrián S, Milagro FI. Plant miR8126-3p and miR8126-5p decrease lipid accumulation through modulation of metabolic genes in a human hepatocyte model that mimics steatosis. Int J Mol Sci. 2024;25:1721.
49. Wang Q, Zhuang X, Mu J, et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun. 2013;4:1867.
50. Huang S, Zhang M, Li X, et al. Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity. J Pharm Anal. 2024;14:101014.
51. Zhang X, Cui Q, Yin L, et al. Ginger-derived vesicle-like nanoparticles loaded with curcumin to alleviate ionizing radiation-induced intestinal damage via gut microbiota regulation. Gut Microbes. 2025;17:2531210.
52. Wang S, He B, Wu H, et al. Plant mRNAs move into a fungal pathogen via extracellular vesicles to reduce infection. Cell Host Microbe. 2024;32:93-105.e6.
53. Ravet A, Zervudacki J, Singla-Rastogi M, et al. Vesicular and non-vesicular extracellular small RNAs direct gene silencing in a plant-interacting bacterium. Nat Commun. 2025;16:3533.
54. Cai Q, He B, Weiberg A, Buck AH, Jin H. Small RNAs and extracellular vesicles: New mechanisms of cross-species communication and innovative tools for disease control. PLoS Pathog. 2019;15:e1008090.
55. Zhou LK, Zhou Z, Jiang XM, et al. Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients. Cell Discov. 2020;6:54.
56. Li P, Tang Y, Chen Y, et al. Honeysuckle-derived exosome-like nanovesicles protect against acute liver failure by modulating gut microbiota. Int J Nanomedicine. 2025;20:12975-92.
57. Wang X, Liu H, Fan H, et al. Ginseng exosomal miRNA ameliorates rheumatoid arthritis by mediating KRAS-MAPK signaling. Int Immunopharmacol. 2025;161:115046.
58. Kim J, Zhang S, Zhu Y, Wang R, Wang J. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines. J Ginseng Res. 2023;47:627-37.
59. Pomatto MAC, Gai C, Negro F, et al. Oral delivery of mRNA vaccine by plant-derived extracellular vesicle carriers. Cells. 2023;12:1826.
60. Pomatto MAC, Gai C, Negro F, et al. Plant-derived extracellular vesicles as a delivery platform for RNA-based vaccine: feasibility study of an oral and intranasal SARS-CoV-2 vaccine. Pharmaceutics. 2023;15:974.
61. Teng Y, Ren Y, Sayed M, et al. Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe. 2018;24:637-52.e8.
62. Yan L, Cao Y, Hou L, et al. Ginger exosome-like nanoparticle-derived miRNA therapeutics: A strategic inhibitor of intestinal inflammation. J Adv Res. 2025;69:1-15.
63. Lukasik A, Brzozowska I, Zielenkiewicz U, Zielenkiewicz P. Detection of plant miRNAs abundance in human breast milk. Int J Mol Sci. 2017;19:37.
64. Zhang F, Liang X, Liu H, Anayyat U, Yang Z, Wang X. Advancements and challenges of plant-derived extracellular vesicles in anti-cancer strategies and drug delivery. Curr Drug Deliv. 2025;22:921-34.
65. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
66. Heintz-Buschart A, Yusuf D, Kaysen A, et al. Small RNA profiling of low biomass samples: identification and removal of contaminants. BMC Biol. 2018;16:52.
67. Lang C, Lin HT, Wu C, Alavi M. In Silico analysis of the sequence and structure of plant microRNAs packaged in extracellular vesicles. Comput Biol Chem. 2022;101:107771.
68. Liu Y, Teng C, Xia R, Meyers BC. PhasiRNAs in plants: their biogenesis, genic sources, and roles in stress responses, development, and reproduction. Plant Cell. 2020;32:3059-80.
69. Chen X, Xing X, Lin S, et al. Plant-derived nanovesicles: harnessing nature’s power for tissue protection and repair. J Nanobiotechnology. 2023;21:445.
70. Urzì O, Gasparro R, Ganji NR, Alessandro R, Raimondo S. Plant-RNA in extracellular vesicles: the secret of cross-kingdom communication. Membranes. 2022;12:352.
71. Teng Y, Luo C, Qiu X, et al. Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites. Nat Commun. 2025;16:1295.
72. Li N, Zhong Z, Wen C, et al. Structural integrity facilitates multi-layer modulation of the brain-metabolome-microbiota network by Lilium lancifolium-derived vesicles in depression. J Nanobiotechnol 2026.
73. Bahri F, Mansoori M, Vafaei S, et al. A comprehensive review on ginger-derived exosome-like nanoparticles as feasible therapeutic nano-agents against diseases. Mater Adv 2024;5:1846-67.
74. Han Y, Guo X, Ji Z, et al. Colon health benefits of plant-derived exosome-like nanoparticles via modulating gut microbiota and immunity. Crit Rev Food Sci Nutr. 2025;65:7718-38.
75. Turner NP. Food-derived extracellular vesicles in the human gastrointestinal tract: Opportunities for personalised nutrition and targeted therapeutics. J Extracell Biol. 2024;3:e154.
76. Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21:719-33.
77. Zhang Y, Wiggins BE, Lawrence C, Petrick J, Ivashuta S, Heck G. Analysis of plant-derived miRNAs in animal small RNA datasets. BMC Genomics. 2012;13:381.
78. Tosar JP, Rovira C, Naya H, Cayota A. Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS. RNA. 2014;20:754-7.
79. Shi R, Tan W, Jin H, et al. MicroRNA-enriched plant-derived exosomes alleviate colitis by modulating systemic immunity, metabolic homeostasis, and gut microbiota. Adv Sci. 2025;12:e05921.
80. Liang H, Zhang S, Fu Z, et al. Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. J Nutr Biochem. 2015;26:505-12.
81. Tosar JP, Gámbaro F, Sanguinetti J, Bonilla B, Witwer KW, Cayota A. Assessment of small RNA sorting into different extracellular fractions revealed by high-throughput sequencing of breast cell lines. Nucleic Acids Res. 2015;43:5601-16.
82. Cui D, Qiao W, Chen W, et al. Anti-tumor immunotherapy of Scutellaria baicalensis-derived vesicles on immune checkpoint modulation in colorectal cancer. Aging Dis. 2026;Epub ahead of print.
83. Lu X, Yu Z, Wang J, et al. The unexpected PD-L1 suppression function of celery-derived extracellular vesicles improves lung cancer chemotherapy efficacy. Extracell Vesicles Circ Nucl Acids. 2024;5:597-613.
84. Han X, Yang Y, Lu Q, et al. Astragalus-derived nano-agonist potentiates chemotherapy by reducing tumor-suppressive macrophages. Acta Pharm Sin B. 2026;16:3934-52.
85. Wang Y, Zeng Y, Liu G, et al. Rosa roxburghii ‐derived exosome‐like nanovesicles alleviate ulcerative colitis based on Th17/Treg immune balance and gut microbiota modulation. Food Frontiers. 2026;7:e70284.
86. Liu B, Lu Y, Chen X, et al. Protective role of shiitake mushroom-derived exosome-like nanoparticles in D-Galactosamine and lipopolysaccharide-induced acute liver injury in mice. Nutrients. 2020;12:477.
87. Wang Y, Zhou Y, Wu Q, et al. Honeysuckle-derived nanovesicles regulate gut microbiota for the treatment of inflammatory bowel disease. Adv Sci. 2025;12:e05208.
88. Xu J, Yu Y, Zhang Y, et al. Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells. Nat Nanotechnol. 2024;19:1569-78.
89. Li J, Luo T, Wang D, et al. Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease. J Adv Res. 2025;68:63-74.
90. Gao B, Huang X, Fu J, et al. Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment. J Nanobiotechnology. 2025;23:261.
91. Guo F, Huang R-S, Li R-H, et al. Sichuan dark tea with a medicine-food-homology formula synergistically alleviates alcohol-associated gut microbiota disturbance, liver steatosis and death in mice. Food Med Homol. 2026;3:9420128.
92. Gao Y. Inflammation and gut microbiota in the alcoholic liver disease. Food Med Homol. 2024;1:9420020.
93. Rinella ME, Lazarus JV, Ratziu V, et al. ; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542-56.
94. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908-22.
95. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202-9.
96. Cao L, Wu Y, Liu K, et al. Cornus officinalis vinegar alters the gut microbiota, regulating lipid droplet changes in nonalcoholic fatty liver disease model mice. Food Med Homol. 2024;1:9420002.
97. Walsh SK, Pettigrew K, Mezzani I, Alaswad I, Bermano G. Role of selenium and 17 β oestradiol in modulating lipid accumulation in in vitro models of obesity and NAFLD. Food Med Homol. 2025;2:9420056.
98. Zou Z, Liu X, Yu J, et al. se in mice.Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disea. J Hepatol. 2024;80:834-45.
99. Zhou M, Shi R, Wu H, et al. Opuntia Milpa Alta-derived vesicles mitigate ulcerative colitis by regulating fatty acid metabolism. J Future Foods. 2026;Epub ahead of print.
100. Liu L, Niu J, Sun Y, et al. Terpenoid-enriched Curcuma wenyujin nanovesicles for suppressing inflammation and restoring lipid homeostasis in MASH. Extracell Vesicles Circ Nucl Acids. 2026;7:1010-28.
101. Guo L, Ding Q, Duan W, et al. Goji-derived exosomes-like nanoparticles ameliorate alcohol-induced acute liver injury by modulating gut microbiota and metabolites. Food Med Homol. 2026;3:9420081.
102. Gao Q, Chen N, Li B, et al. Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route. J Nanobiotechnology. 2024;22:4.
103. Kim JS, Kim DH, Gil MC, et al. Pomegranate-derived exosome-like nanovesicles alleviate binge alcohol-induced leaky gut and liver injury. J Med Food. 2023;Epub ahead of print.
104. Li P, Wu Q, Zhou Y, et al. Honeysuckle-derived exosome-like nanovesicles ameliorate metabolic-associated fatty liver disease by modulating gut microbiota and its metabolites. Nano Res. 2025;18:94907986.
105. Zheng Y, Wang T, Zhang J, et al. Plant-derived nanovesicles: a promising frontier in tissue repair and antiaging. J Agric Food Chem. 2025;73:13159-77.
107. Xie Q, Gu J, Sun Y, et al. Therapeutic potential of ginger exosome-like nanoparticles for alleviating periodontitis-induced tissue damage. Int J Nanomedicine. 2024;19:11941-56.
108. Liu T, Wang H, Wang R, et al. American ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) mitigate doxorubicin-induced cardiotoxicity by inhibiting GPX4-mediated ferroptosis. Phytomedicine. 2026;152:157861.
109. Feng J, Xiu Q, Huang Y, Troyer Z, Li B, Zheng L. Plant-derived vesicle-like nanoparticles as promising biotherapeutic tools: present and future. Adv Mater. 2023;35:e2207826.
110. Savcı Y, Kırbaş OK, Bozkurt BT, et al. Grapefruit-derived extracellular vesicles as a promising cell-free therapeutic tool for wound healing. Food Funct. 2021;12:5144-56.
111. Hao Y, Yang Q, Zhang H, Bai C, Liu X, Gao Y. Ginger-derived extracellular vesicles: a natural solution for alopecia. Curr Drug Deliv. 2026;23:111-24.
112. Yang N, Wang Y, Liu H, Li T, Lu M, Lu R. Plant-derived extracellular vesicles in facial aesthetics. Extracell Vesicles Circ Nucl Acids. 2025;6:651-68.
113. Tang Y, Li P, Chen Y, et al. A natural derivative from exosome of Inula japonica Thunb.: Preventing acute lung injury through the gut microbiota-metabolites axis. Colloids Surf B Biointerfaces. 2026;264:115654.
114. Rabienezhad Ganji N. Functional characterization of mammalian and plant extracellular vesicles as systems for cancer treatment. 2024. Available from https://tesidottorato.depositolegale.it/handle/20.500.14242/126876. [accessed 13 October 2026].
115. Umezu T, Takanashi M, Murakami Y, et al. Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration. Mol Ther Methods Clin Dev. 2021;21:199-208.
116. Chen J, Wei C, Pan C, et al. Genetically engineered Bacillus subtilis-derived extracellular vesicles Alleviates Ulcerative colitis by restoring intestinal barrier and regulating gut microbiota. Chemical Engineering Journal. 2025;512:162727.
117. Jing R, Zhang L, Li R, et al. Milk-derived extracellular vesicles functionalized with anti-tumour necrosis factor-α nanobody and anti-microbial peptide alleviate ulcerative colitis in mice. J Extracell Vesicles. 2024;13:e12462.
118. Lamson NG, Berger A, Fein KC, Whitehead KA. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. Nat Biomed Eng. 2020;4:84-96.
119. Song Z, Lin Y, Zhang X, et al. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. Int J Nanomedicine. 2017;12:1941-58.
120. Zhang W, Fu X, Xie J, Pan H, Han W, Huang W. miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways. Mol Ther Nucleic Acids. 2021;24:264-73.
121. Garo LP, Ajay AK, Fujiwara M, et al. MicroRNA-146a limits tumorigenic inflammation in colorectal cancer. Nat Commun. 2021;12:2419.
122. Cai Y, Zhang L, Zhang Y, Lu R. Plant-derived exosomes as a drug-delivery approach for the treatment of inflammatory bowel disease and colitis-associated cancer. Pharmaceutics. 2022;14:822.
123. Xu XH, Yuan TJ, Dad HA, et al. Plant exosomes as novel nanoplatforms for microRNA transfer stimulate neural differentiation of stem cells in vitro and in vivo. Nano Lett. 2021;21:8151-9.
124. Calzoni E, Bertoldi A, Cusumano G, Buratta S, Urbanelli L, Emiliani C. Plant-derived extracellular vesicles: natural nanocarriers for biotechnological drugs. Processes. 2024;12:2938.
125. Fang Z, Liu K. Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release. 2022;350:389-400.
126. Shu F, Yang N, Yu F, Luo P, Chen G, Chen J. Temporary immersion bioreactor system: an excellent strategy for preparing high-quality controlled extracellular vesicles from food and medicine homology plants. Food Med Homol. 2025;2:9420123.
127. Zhao B, Lin H, Jiang X, et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery. Theranostics. 2024;14:4598-621.
128. Mun JG, Song DH, Kee JY, Han Y. Recent advances in the isolation strategies of plant-derived exosomes and their therapeutic applications. Curr Issues Mol Biol. 2025;47:144.
129. Liu YC, Chen WL, Kung WH, Huang HD. Plant miRNAs found in human circulating system provide evidences of cross kingdom RNAi. BMC Genomics. 2017;18:112.
130. Langellotto MD, Rassu G, Serri C, Demartis S, Giunchedi P, Gavini E. Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds. Drug Deliv Transl Res. 2025;15:831-45.
131. Wu C, Li J, Huang K, et al. Advances in preparation and engineering of plant-derived extracellular vesicles for nutrition intervention. Food Chem. 2024;457:140199.
